Phosphorylation assays Sample Clauses

Phosphorylation assays. HEK-293T/17 cells were plated in 6-well plates (Corning) 20-24 h prior to transfection. Each well was transfected with 0.33µg of receptor plasmid or empty vector. After 36-48h, cells were serum-starved for 2h before drug treatment by replacing complete growth medium with DMEM. To initiate stimulation, half (1ml) of the DMEM was removed and slowly replaced with 1mL fresh DMEM, containing a 2X concentration of vehicle, prosaptide, or head activator (HA) peptide. Plates were carefully returned to a 37°C incubator for 10 min. Following stimulation, cells were rapidly harvested in Laemmli buffer. Samples were sonicated and loaded into 4-20% Tris-Glycine gels (Bio-Rad) for SDS-PAGE, and then transferred to nitrocellulose membranes (Bio-Rad). Membranes were blocked via shaking at RT for 30 min in Odyssey blocking buffer and incubated overnight with shaking at 4 °C with mouse anti-phospho ERK (Santa Xxxx) and rabbit anti-total ERK (Cell Signaling Technologies) or rabbit anti-phospho AKT (Cell Signaling Technologies and mouse anti-total AKT (Cell Signaling Technologies) in antibody buffer (equal parts blocking buffer and PBS + 0.1% Tween-20). Membranes were then washed three times in a wash buffer (PBS with 0.1% Tween-20) and incubated with Alexa-fluor anti-mouse 700-nm conjugated secondary antibody (1:20,000; Invitrogen) and anti-rabbit 800-nm conjugated secondary antibody (1:20,000; Li-Cor) for 30 min in antibody buffer. Blots were washed three times and rinsed in PBS until they were visualized on an Odyssey Imaging System (Li-Cor). Protein quantification was done using densitometry, performed with ImageJ software
AutoNDA by SimpleDocs

Related to Phosphorylation assays

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • MSAA Indicator Technical Specification Document This Agreement shall be interpreted with reference to the MSAA Indicator Technical Specifications document.

  • Insulin Insulin will be treated as a prescription drug subject to a separate copay for each type prescribed.

  • Rhytidectomy Scar revision, regardless of symptoms. • Sclerotherapy for spider veins. • Skin tag removal. • Subcutaneous injection of filling material. • Suction assisted Lipectomy. • Tattooing or tattoo removal except tattooing of the nipple/areola related to a mastectomy. • Treatment of vitiligo. • Standby services of an assistant surgeon or anesthesiologist. • Orthodontic services related to orthognathic surgery. • Cosmetic procedures when performed primarily: o to refine or reshape body structures or dental structures that are not functionally impaired; o to improve appearance or self-esteem; or o for other psychological, psychiatric or emotional reasons. • Drugs, biological products, hospital charges, pathology, radiology fees and charges for surgeons, assistant surgeons, attending physicians and any other incidental services, which are related to cosmetic surgery.

  • SHOP DRAWINGS, PRODUCT DATA AND SAMPLES 4.12.1 Shop Drawings are drawings, diagrams, schedules and other, data specially prepared for the Work by the Contractor or any Subcontractor, manufacturer, supplier or distributor to illustrate some portion of the Work.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

Time is Money Join Law Insider Premium to draft better contracts faster.